PT  - JOURNAL ARTICLE
AU  - Ng, Jeremy Y.
AU  - Liu, Henry
AU  - Masood, Mehvish
AU  - Syed, Niveen
AU  - Stephen, Dimity
AU  - Ayala, Ana Patricia
AU  - Sabé, Michel
AU  - Solmi, Marco
AU  - Waltman, Ludo
AU  - Haustein, Stefanie
AU  - Moher, David
TI  - Guidance for the Reporting of Bibliometric Analyses: A Scoping Review
AID  - 10.1101/2024.08.26.24312538
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.08.26.24312538
4099  - http://medrxiv.org/content/early/2024/08/28/2024.08.26.24312538.short
4100  - http://medrxiv.org/content/early/2024/08/28/2024.08.26.24312538.full
AB  - Despite the growth in the number of bibliometric analyses published in the peer-reviewed literature, few articles provide guidance on methods and reporting to ensure reliability, robustness, and reproducibility. Consequently, the quality of reporting in existing bibliometric studies varies greatly. In response, we are developing a preliminary Guidance List for the repOrting of Bibliometric AnaLyses (GLOBAL), a reporting guideline for bibliometric analyses. This paper outlines a scoping review that aims to identify and categorise bibliometric recommendations from the literature to develop an initial list of candidate items for the GLOBAL. Five bibliographic databases, three preprint servers, and grey literature were systematically searched. Twenty-three out of 48,750 records fulfilled the inclusion criteria. Six documents contained bibliometric reporting recommendations based on a complete or partial literature review; all other sources (n = 17) contained opinion-based recommendations. A 32-item recommendation list that will inform the development of the GLOBAL was created. A paucity of evidence-based studies on bibliometric reporting exists in the literature, supporting the need to create a reporting guideline for bibliometric analyses. The next step in the GLOBAL project will focus on conducting a two-round Delphi study to achieve consensus on which of the 32 items should be included in GLOBAL.Competing Interest StatementMarco Solmi received a honoraria/has been a consultant for Angelini, AbbVie, Boehringer Ingelheim, Lundbeck, and Otsuka.Clinical Protocols https://doi.org/10.17605/OSF.IO/7SGW2 Funding StatementJeremy Y Ng's postdoctoral fellowship was funded by a MITACS Elevate Award (Award #: IT36020) co-funded by EBSCO Health. We also gratefully acknowledge funding provided by Cabells and Clarivate.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are included in this manuscript or posted on the Open Science Framework. https://doi.org/10.17605/OSF.IO/WYP63